The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck

Journal of Oral Pathology and Medicine

Volumn 33, Issue 9, 2004, Pages 538-542

  Koscielny, S ^a   Eggeling, F V ^a   Dahse, R ^a   Fiedler, W ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Head and neck cancer; Head and neck surgery; Prognosis; Recurrences; Telomerase

Indexed keywords

TELOMERASE;

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR LOCALIZATION;

CARCINOMA, SQUAMOUS CELL; ENZYME ACTIVATION; ENZYME REACTIVATORS; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; HYPOPHARYNGEAL NEOPLASMS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TELOMERASE;

EID: 4844227613     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00232.x     Document Type: Article

References (23)

1. Harley CB, Sherwood SW. Telomerase, checkpoints and cancer Cancer Surv 1997; 29: 263-84.
2. Fossel M. Cell senescence in human aging and disease. Ann N Y Acad Sci 2002; 959: 14-23.
3. Smith JR, Pereira-Smith OM. Replicative senescence: implications for in vivo aging and tumor suppression. Science 1996; 273: 63-7.
4. Ishioka S, Yamakido M. Activation of telomerase in human lymphocytes and hematopoetic progenitor cells. J Immunol 1995; 155: 3711-5.
5. Mao L, Naggar AK, Fan AH, et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissue. Cancer Res 1996; 56: 5600-4.
6. Kagata HY, Tsukuda M, Mochimatsu I, Kubota A, Furukawa MK, Yasumoto S. Telomerase activity of tumors in the head and neck. Nip Jibiinkoka Gakkai Kaiho 1998; 101: 205-11.
7. Koscielny S, Fiedler W, Dahse R, Beleites E. Reactivation of telomerase in carcinogenesis due to squamous cell carcinomas in head and neck. Eur Arch Otorhinlaryngol 1998; 255: 48.
8. Loughran O, Clark LJ, Bond J, et al. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene 1997; 14: 1955-64.
9. Miyoshi Y, Tsukinoki K, Imaizumi T, et al. Telomerase activity in oral cancer. Oral Oncol 1999; 35: 283-9.
10. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-7.
11. Fiedler W, Dahse R, Schlichter A, et al. Telomerase activity and telomere length in different areas of renal cell carcinoma. Int J Oncol 1996; 9: 1227-32.
12. Steel M. Telomerase that shapes our ends. Lancet 1995; 345: 935-6.
13. Sumida T, Sogawa K, Hamakawa H, Sugita A, Tanioka H, Ueda N. Detection of telomerase activity in oral lesions. Oral Pathol Med 1995; 27: 111-5.
14. Curran AJ, Gullane PJ, Irish J, Macmillan C, Freeman J, Kamel-Reid S. Telomerase activity is upregulated in laryngeal squamous cell carcinoma. Laryngoscope 2000; 110: 391-6.
15. Ferlicot S, Paradis V, Dargere D, Monges G, Bedossa P. Detection of telomerase in hepatocellular carcinomas using a PCR ELISA assay: comparison with hTR expression. J Clin Pathol 1999; 52: 725-9.
16. Carey LA, Kim NW, Goodman S, et al. Telomerase activity and prognosis in primary breast cancers. J Clin Oncol 1999; 17: 3075-81.
17. Bieche I, Nogues C, Paradis V, et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000; 6: 452-9.
18. Hiyama K, Hirai Y, Kyoizumi S, et al. Overexpression of human telomerase RNA is an early event in oesophageal carcinogenesis. Virchows Arch 1999; 434: 483-7.
19. Halvorsen OJ, Hostmark J, Haukaas S, Hoisaeter PA, Akslen LA. Prognostic significance of p16 and CDK4 proteins in localised prostate carcinoma. Cancer 2000; 88: 416-24.
20. Fujioka T, Hasegawa M, Suzuki Y, et al. Telomerase activity in human renal cell carcinoma. Int J Urol 2000; 7: 16-21.
21. Sumida T, Hamakawa H, Kayahara H, et al. Clinical usefulness of telomerase assay for the detection of lymph node metastasis in patients with oral malignancy. Arch Pathol Lab Med 2000; 124: 398-400.
22. Hiyama E, Yokoyama T, Tatsumoto N. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 3258-61.
23. Onoda N, Ishikawa T, Yoshikawa K, et al. Telomerase activity in thyroid tumors. Oncol Rep 1998; 5: 1447-50.